D-1064-2020 Class II Terminated

Recalled by Fresenius Medical Care Holdings, Inc. — Waltham, MA

FDA drug recall D-1064-2020 was initiated by Fresenius Medical Care Holdings, Inc. on Mar 5, 2020 and is designated Class II. Reason for recall: CGMP Deviation: Chemical indicators were not positioned properly during sterilization process. The recall status is terminated (terminated Feb 3, 2023). Affected quantity: 32,592 bags.

Recall details

Product Type
Drugs
Report Date
Mar 25, 2020
Initiation Date
Mar 5, 2020
Termination Date
Feb 3, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
32,592 bags

Product description

Sodium Chloride 0.9% Injection, USP, 1000 mL bags, Rx only, Manufactured by: Fresenius Medical Care North America, Waltham, MA 02451

Reason for recall

CGMP Deviation: Chemical indicators were not positioned properly during sterilization process.

Distribution pattern

Product was distributed throughout the United States.

Code information

Lot #: 19EG02012, 19EG02019, Exp. Date 05/2020; 19DG02050, Exp. Date 04/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1064-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1064-2020. Report a data issue: hello@regdatalab.com.